Brian D Lawenda

Summary

Affiliation: Naval Medical Center
Country: USA

Publications

  1. ncbi Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Brian D Lawenda
    Radiation Oncology Division, Breast Health Center, Naval Medical Center San Diego, San Diego, CA, USA
    J Natl Cancer Inst 100:773-83. 2008
  2. ncbi Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review
    Brian D Lawenda
    Department of Radiation Oncology, Naval Medical Center San Diego, San Diego, CA 92134 1014, USA
    Ear Nose Throat J 87:634-43. 2008
  3. ncbi Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment
    Brian D Lawenda
    Radiation Oncology, Naval Medical Center, San Diego, CA, 92134, USA
    CA Cancer J Clin 59:8-24. 2009
  4. ncbi Response to "Radiation therapeutic gain and Asian botanicals," by Stephen Sagar
    Brian D Lawenda
    Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    Integr Cancer Ther 9:14-5. 2010
  5. ncbi Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma
    Brian D Lawenda
    Division of Radiation Oncology, Naval Medical Center, San Diego, CA 92134, USA
    J Soc Integr Oncol 5:11-7. 2007
  6. ncbi Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant
    Brian D Lawenda
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 56:671-80. 2003
  7. ncbi Integrative oncology: tapping into a research goldmine
    Brian D Lawenda
    Uniformed Services University of the Health Sciences, Bethesda, Maryland, and The Breast Health Center, Naval Medical Center San Diego, San Diego, California 92134, USA
    Cancer J 12:455-8. 2006

Detail Information

Publications7

  1. ncbi Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Brian D Lawenda
    Radiation Oncology Division, Breast Health Center, Naval Medical Center San Diego, San Diego, CA, USA
    J Natl Cancer Inst 100:773-83. 2008
    ....
  2. ncbi Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review
    Brian D Lawenda
    Department of Radiation Oncology, Naval Medical Center San Diego, San Diego, CA 92134 1014, USA
    Ear Nose Throat J 87:634-43. 2008
    ..We also found a trend toward improved regional control of the clinically negative neck with the addition of radiation therapy...
  3. ncbi Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment
    Brian D Lawenda
    Radiation Oncology, Naval Medical Center, San Diego, CA, 92134, USA
    CA Cancer J Clin 59:8-24. 2009
    ..It is hoped that this review will convey the importance of the early identification and management of this incurable disorder because this is essential to minimizing its complications...
  4. ncbi Response to "Radiation therapeutic gain and Asian botanicals," by Stephen Sagar
    Brian D Lawenda
    Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    Integr Cancer Ther 9:14-5. 2010
    ..It will be important to evaluate these botanicals for efficacy, tumor specificity, and safety profiles before they can be recommended during radiation therapy...
  5. ncbi Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma
    Brian D Lawenda
    Division of Radiation Oncology, Naval Medical Center, San Diego, CA 92134, USA
    J Soc Integr Oncol 5:11-7. 2007
    ..As supplementation with VE radioprotected normal tissue, additional studies on this putative benefit are recommended...
  6. ncbi Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant
    Brian D Lawenda
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 56:671-80. 2003
    ..Only the long-term follow-up of this and other implant studies will allow an understanding of the total radiation dose necessary for tumor control and the volume of breast that requires treatment...
  7. ncbi Integrative oncology: tapping into a research goldmine
    Brian D Lawenda
    Uniformed Services University of the Health Sciences, Bethesda, Maryland, and The Breast Health Center, Naval Medical Center San Diego, San Diego, California 92134, USA
    Cancer J 12:455-8. 2006